Goswami Debkalpa, Kazim Madihah, Nguyen Christopher T
Cardiovascular Innovation Research Center, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):271-277. doi: 10.1007/s11936-024-01045-3. Epub 2024 Jun 21.
3D printing (3DP) technology has emerged as a valuable tool for surgeons and cardiovascular interventionalists in developing and tailoring patient-specific treatment strategies, especially in complex and rare cases. This short review covers advances, primarily in the last three years, in the use of 3DP in the diagnosis and management of heart failure and related cardiovascular conditions.
Latest studies include utilization of 3DP in ventricular assist device placement, congenital heart disease identification and treatment, pre-operative planning and management in hypertrophic cardiomyopathy, clinician as well as patient education, and benchtop mock circulatory loops.
Studies reported benefits for patients including significantly reduced operation time, potential for lower radiation exposure, shorter mechanical ventilation times, lower intraoperative blood loss, and less total hospitalization time, as a result of the use of 3DP. As 3DP technology continues to evolve, clinicians, basic science researchers, engineers, and regulatory authorities must collaborate closely to optimize the utilization of 3D printing technology in the diagnosis and management of heart failure.
3D打印（3DP）技术已成为外科医生和心血管介入专家制定和定制患者特异性治疗策略的重要工具，尤其是在复杂和罕见病例中。本简短综述涵盖了主要在过去三年中3DP在心力衰竭及相关心血管疾病诊断和管理中的应用进展。
最新研究包括3DP在心室辅助装置植入、先天性心脏病识别与治疗、肥厚型心肌病术前规划与管理、临床医生及患者教育以及台式模拟循环回路中的应用。
研究报告称，使用3DP对患者有益，包括显著缩短手术时间、降低辐射暴露可能性、缩短机械通气时间、减少术中失血量以及缩短总住院时间。随着3DP技术不断发展，临床医生、基础科学研究人员、工程师和监管机构必须密切合作，以优化3D打印技术在心力衰竭诊断和管理中的应用。
